Have you been affected by a UK shortage of diabetes and weight loss drugs?

There is a shortage of liraglutide and semaglutide, also licensed under the brand names Victoza and Ozempic respectively Photograph: Joel Saget/AFP/Getty Images

Last month the Department of Health and Social Care warned of a national shortage of certain drugs used to manage type 2 diabetes, known as GLP-1 receptor agonists.

These include the drugs liraglutide and semaglutide, which are licensed for diabetes management under the brand names Victoza and Ozempic respectively. There is also a shortage of liraglutide licensed for weight loss under the brand name Saxenda.